Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Lagrange, A
Howe G, Westhoff C, Vessey M, Yeates D
9.19.2 kDa Structural Modification Arginine substitution at position 3 plus 13-amino-acid N-terminal extension Fill Amount 1 mg Form Lyophilized Powder Reconstitution Status Not Reconstituted Container Type Sealed Vial Documentation Batch-Level COA Available Intended Use Laboratory Research Only Handling Qualified Personnel Only Storage Store According to Product Label Research Material Identification IGF-1 LR3 is distinguished from standard IGF-1 by its defined structural modifications, including the position-3 arginine substitution and extended N-terminal sequence
Melanotan-2 is a different story
US$ 20.57
US$ 22.82
US$ 27.29
US$ 20.92
